February 17, 2026
Beyond the Scale: Navigating the New Era of Single, Dual, and Triple Incretin Agonists
The landscape of metabolic medicine is shifting at a quantum pace. What began with the quiet introduction of once-weekly GLP-1 agonists for diabetes has erupted into a…